3276 related articles for article (PubMed ID: 13130303)
1. Targeting HIF-1 for cancer therapy.
Semenza GL
Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1 (HIF-1) in cancer.
Quintero M; Mackenzie N; Brennan PA
Eur J Surg Oncol; 2004 Jun; 30(5):465-8. PubMed ID: 15135470
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
4. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
Krishnamachary B; Berg-Dixon S; Kelly B; Agani F; Feldser D; Ferreira G; Iyer N; LaRusch J; Pak B; Taghavi P; Semenza GL
Cancer Res; 2003 Mar; 63(5):1138-43. PubMed ID: 12615733
[TBL] [Abstract][Full Text] [Related]
5. [The hypoxia-inducible factor HIF as a new target in cancer research].
L'Allemain G
Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
Bacon AL; Harris AL
Ann Med; 2004; 36(7):530-9. PubMed ID: 15513303
[TBL] [Abstract][Full Text] [Related]
7. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
8. 'The metabolism of tumours': 70 years later.
Semenza GL; Artemov D; Bedi A; Bhujwalla Z; Chiles K; Feldser D; Laughner E; Ravi R; Simons J; Taghavi P; Zhong H
Novartis Found Symp; 2001; 240():251-60; discussion 260-4. PubMed ID: 11727934
[TBL] [Abstract][Full Text] [Related]
9. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
[TBL] [Abstract][Full Text] [Related]
10. Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.
Abraham D; Krenn K; Seebacher G; Paulus P; Klepetko W; Aharinejad S
Ann Thorac Surg; 2004 May; 77(5):1751-5. PubMed ID: 15111179
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.
Zhong H; Semenza GL; Simons JW; De Marzo AM
Cancer Detect Prev; 2004; 28(2):88-93. PubMed ID: 15068831
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1alpha in oral cancer.
Brennan PA; Mackenzie N; Quintero M
J Oral Pathol Med; 2005 Aug; 34(7):385-9. PubMed ID: 16011605
[TBL] [Abstract][Full Text] [Related]
13. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.
Papandreou I; Krishna C; Kaper F; Cai D; Giaccia AJ; Denko NC
Cancer Res; 2005 Apr; 65(8):3171-8. PubMed ID: 15833847
[TBL] [Abstract][Full Text] [Related]
14. HIF at the crossroads between ischemia and carcinogenesis.
Paul SA; Simons JW; Mabjeesh NJ
J Cell Physiol; 2004 Jul; 200(1):20-30. PubMed ID: 15137054
[TBL] [Abstract][Full Text] [Related]
15. HIF-1 as a target for drug development.
Giaccia A; Siim BG; Johnson RS
Nat Rev Drug Discov; 2003 Oct; 2(10):803-11. PubMed ID: 14526383
[TBL] [Abstract][Full Text] [Related]
16. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumors through the HIF system.
Ratcliffe PJ; Pugh CW; Maxwell PH
Nat Med; 2000 Dec; 6(12):1315-6. PubMed ID: 11100107
[No Abstract] [Full Text] [Related]
18. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
19. Macrophage infiltration and angiogenesis in human malignancy.
Knowles H; Leek R; Harris AL
Novartis Found Symp; 2004; 256():189-200; discussion 200-4, 259-69. PubMed ID: 15027491
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HIF-1 inhibitors as anticancer agents.
Semenza GL
Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
